Please assess the completion status of the following clinical trial:

Trial Title: HR-lowering Efficacy and Respiratory Safety of Ivabradine in Patients With Obstructive Airway Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* documented diagnosis of asthma or COPD in accordance with guidelines~* stable condition, defined as a disease without exacerbation for at least 1 month prior to study enrolment~* mean HR in holter ECG recording of ≥ 60 bpm~Exclusion Criteria:~* disease exacerbation in previous month~* inability to understand instructions on study procedures

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Ivabradine-Placebo (Type: ACTIVE_COMPARATOR): None
- Placebo-Ivabradine (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).